Supplements

Best Supplements for SIBO: What the Clinical Trials Show

SIBO affects an estimated 6–15% of healthy adults and up to 80% of people with IBS — yet antibiotic relapse rates top 44% within nine months. The clinical evidence for herbal antimicrobials, gut-lining nutrients, and biofilm disruptors is stronger than most people realize, and the right protocol depends entirely on which SIBO variant you have.

Jared Murray ·Co-Founder & Head of Health Research, Ones · ·10 min read
SIBOherbal antimicrobialsgut healthberberineintestinal permeability
Best Supplements for SIBO: What the Clinical Trials Show

What Is SIBO and Why Does It Keep Coming Back?

SIBO occurs when bacteria that normally colonize the colon migrate into the small intestine and multiply beyond normal levels (typically >10³ CFU/mL in aspirate or a positive lactulose/glucose breath test). The result is fermentation of carbohydrates before they can be absorbed, producing hydrogen or methane gas that drives bloating, cramping, diarrhea, constipation, and nutrient malabsorption.

Relapse rates after antibiotic treatment (most commonly rifaximin) run as high as 44% within nine months (Lauritano et al., Alimentary Pharmacology & Therapeutics 2008; PMID: 18429927). The core problem is that rifaximin eliminates bacteria but does nothing to restore the migrating motor complex (MMC) — the wave-like muscular contraction that sweeps residual bacteria from the small intestine between meals. Without restored MMC activity, recolonization is a matter of when, not if. This is why researchers have been investigating herbal antimicrobials, prokinetics, and gut-supportive nutrients — not as replacements for medical treatment, but as adjuncts that target root causes like impaired MMC activity, low stomach acid, and intestinal permeability.

Three SIBO subtypes matter clinically: hydrogen-dominant (typically diarrhea-predominant, driven by Escherichia coli, Klebsiella, and Enterococcus species), methane-dominant or intestinal methanogen overgrowth (IMO, constipation-predominant, driven by archaea like Methanobrevibacter smithii), and the emerging hydrogen sulfide variant (linked to Desulfovibrio species and causing symptoms similar to hydrogen-dominant SIBO but with a distinctive rotten-egg odor). Supplement selection differs meaningfully across these subtypes, which is why a one-size protocol rarely succeeds long term.

---

The Clinical Case for Herbal Antimicrobials

The most compelling head-to-head data comparing botanical and pharmaceutical protocols comes from a 2014 study published in Global Advances in Health and Medicine. Researchers randomized 104 patients with SIBO confirmed by lactulose breath test to either rifaximin (1,200 mg/day for 10 days) or an herbal antimicrobial protocol using formulas containing berberine, oregano oil, and other botanicals. Breath-test normalization occurred in 46% of the herbal group versus 34% in the rifaximin group — a non-inferior result that reached statistical significance (Chedid et al., Global Advances in Health and Medicine 2014; PMID: 24891990). Notably, the herbal protocol was run for four weeks — longer than the standard rifaximin course — which may partly explain the stronger outcome, and underscores that botanical protocols typically require more time to work.

Berberine

Berberine is the most researched botanical for gut dysbiosis. It exerts antimicrobial activity against gram-positive and gram-negative bacteria by disrupting cell membrane integrity and inhibiting DNA gyrase. A 2015 randomized controlled trial in patients with type 2 diabetes and concurrent gut dysbiosis found that 500 mg berberine three times daily over 13 weeks significantly shifted the composition of the gut microbiome toward commensals and away from opportunistic species (Zhang et al., PLOS ONE 2015; PMID: 25559254). Berberine also activates AMP-kinase in intestinal epithelial cells, reducing inflammatory signaling that drives permeability. An important caveat: berberine is a potent inhibitor of CYP3A4 and P-glycoprotein, meaning it can raise plasma levels of drugs like cyclosporine and certain statins. Anyone on prescription medications should confirm compatibility with their prescriber before using berberine at therapeutic doses.

Oregano Oil (Carvacrol)

Oregano oil's active constituent, carvacrol, disrupts bacterial and fungal cell membranes by intercalating into the phospholipid bilayer and altering ion permeability, which ultimately collapses the proton motive force the bacteria need to survive. The in-vitro evidence is robust, and the 2014 Chedid trial above used oregano-containing formulas as part of its herbal arm. Clinically, oregano oil is used at 200–600 mg/day as part of a 4–6-week herbal antimicrobial course. Because carvacrol has some activity against commensal Lactobacillus species as well, practitioners commonly pair it with a post-treatment probiotic restoration phase rather than using it indefinitely.

Allicin (Garlic-Derived)

Allicin has specific activity against methane-producing archaea (Methanobrevibacter smithii), making it particularly relevant for methane-dominant SIBO (IMO). Unlike hydrogen-dominant SIBO, IMO does not respond as predictably to rifaximin alone — neomycin is typically added, with its attendant side-effect profile. Allicin-based protocols offer a lower-risk alternative: clinicians at Johns Hopkins have incorporated stabilized allicin as an alternative to neomycin for the methane variant. Doses used range from 450–900 mg/day of stabilized allicin (not raw garlic, which contains negligible allicin after stomach acid degradation). A practical note: allicin supplements degrade quickly when exposed to heat and light; enteric-coated or refrigerated forms maintain potency significantly better than shelf-stable capsules stored at room temperature.

---

Probiotics and Prebiotics: Nuanced Evidence

The role of probiotics in SIBO is controversial. Some gastroenterologists caution that adding live bacteria to an already overpopulated small intestine could worsen symptoms. However, a meta-analysis published in the Journal of Clinical Gastroenterology found that Lactobacillus strains reduced breath hydrogen levels and improved bloating scores compared to placebo across five trials (Zhong et al., 2010). The key distinction is strain selection and timing: most evidence supports introducing probiotics after an antimicrobial course, not during. Soil-based organisms (SBOs) such as Bacillus coagulans and Bacillus subtilis are increasingly used in SIBO contexts because they are spore-forming, transient colonizers of the small intestine rather than persistent residents — a potentially safer option for people who worsen on standard Lactobacillus products.

For constipation-predominant presentations, evidence-backed probiotic strains such as Bifidobacterium lactis BB-12 and Lactobacillus reuteri DSM 17938 have demonstrated transit time improvements in RCTs. These strains are less likely to colonize the small bowel and more likely to restore large-intestinal microbiota balance after SIBO treatment.

Partially hydrolyzed guar gum (PHGG) at 5 g/day has shown promise as a prebiotic fiber that supports MMC function without feeding small-intestinal bacteria — a meaningful distinction compared to FOS or inulin, which can worsen symptoms in active SIBO. A randomized study demonstrated that adding PHGG to rifaximin therapy improved breath-test normalization rates compared to rifaximin alone (Furnari et al., Journal of Clinical Gastroenterology 2010; PMID: 20216468), suggesting that prokinetic support through the enteric nervous system is a genuine therapeutic lever, not a theoretical one.

---

Methane-dominant SIBO and IMO almost universally present with constipation rather than diarrhea. Methane gas directly slows intestinal transit by acting on smooth muscle receptors — specifically, by stimulating mu-opioid receptors in the enteric nervous system, reducing propulsive peristalsis by as much as 59% in animal models. Beyond antimicrobials targeting the archaea, several supplements address the constipation itself:

  • Magnesium citrate or glycinate (300–400 mg/day): Draws water into the colon osmotically and relaxes smooth muscle via calcium channel antagonism. This dual mechanism makes magnesium particularly well-suited to methane-dominant presentations where both water content and motility are impaired.
  • Triphala (500–1,000 mg/day): An Ayurvedic combination of Terminalia chebula, Terminalia bellirica, and Phyllanthus emblica with demonstrated laxative and gut-motility effects. A randomized controlled trial demonstrated significant improvement in constipation scores, bloating, and abdominal pain versus placebo over four weeks (Tarasiuk et al., European Journal of Gastroenterology & Hepatology 2021; PMID: 32796217).
  • 5-HTP (50–100 mg/day): A serotonin precursor that may support gut motility through the enteric nervous system; approximately 95% of the body's serotonin is synthesized in enterochromaffin cells of the gut, where it coordinates peristalsis via 5-HT4 receptor activation.
  • Ginger root extract (500–1,000 mg/day): Accelerates gastric emptying and stimulates the MMC via 5-HT3 and motilin receptor pathways — directly relevant to SIBO recurrence prevention. A systematic review of nine RCTs confirmed ginger's superiority over placebo for gastric emptying time (Hu et al., PLOS ONE 2011; PMID: 21612543).

For a broader look at constipation-focused supplement evidence, clinical trial data on the best probiotics for constipation provides useful complementary reading alongside these motility-targeted options.

---

Best Supplements for Acid Reflux That Overlaps with SIBO

SIBO and gastroesophageal reflux frequently co-occur. Low stomach acid (hypochlorhydria) is both a consequence and a driver of SIBO — without adequate acid, bacteria entering from the mouth are not killed before reaching the small intestine. Addressing acid status is therefore a structural part of any SIBO protocol.

  • Betaine HCl (500–2,000 mg with protein-containing meals): Temporarily lowers gastric pH to aid protein digestion and reduce bacterial translocation from stomach to small intestine. Used clinically when hypochlorhydria is confirmed by symptom challenge or Heidelberg pH testing.
  • Deglycyrrhizinated licorice (DGL, 380–760 mg before meals): Protects gastric mucosa without suppressing acid. DGL has had the glycyrrhizin removed to eliminate blood-pressure-raising effects, making it safe for long-term use. A systematic review noted DGL's efficacy for peptic symptoms and its favorable safety profile compared to antacids (Alam et al., Phytotherapy Research 2022).
  • Zinc-carnosine (75 mg/day): Supports gastric mucosal integrity. A double-blind RCT in 258 patients demonstrated significant improvement in gastric symptoms and mucosal healing markers over eight weeks (Suzuki et al., Alimentary Pharmacology & Therapeutics 2009; PMID: 19366359).
  • Digestive enzymes (amylase, lipase, protease): Reduce fermentable substrate that feeds small-intestinal bacteria by improving upstream digestion, thereby reducing the carbohydrate load available for bacterial fermentation.

Note that proton pump inhibitors (PPIs), while effective for reflux symptoms, increase SIBO risk by approximately 2.3-fold in long-term users (Lo & Chan, Clinical Gastroenterology and Hepatology 2013; PMID: 23270866). If you are on a PPI, discuss alternatives with your healthcare provider before starting a SIBO protocol.

---

Gut Lining Support: Nutrients That Repair Permeability

Bacterial fermentation in the small intestine produces lipopolysaccharides (LPS) that damage tight-junction proteins, contributing to intestinal permeability — commonly called "leaky gut." Rebuilding the gut lining runs in parallel with antimicrobial therapy, and arguably should be continued for weeks after the antimicrobial phase ends.

NutrientMechanismTypical Clinical Dose
L-GlutaminePrimary fuel for enterocytes; restores tight junctions5–10 g/day
Zinc (as picolinate or carnosine)Tight-junction protein synthesis; mucosal defense15–30 mg/day
Vitamin D3Upregulates claudin-2 and occludin expression2,000–5,000 IU/day
ColostrumIgA and growth factors support mucosal immunity1–2 g/day
QuercetinStabilizes mast cells; reduces histamine-driven permeability500–1,000 mg/day

Zinc deserves special attention here. Beyond gut lining support, understanding who should avoid high-dose zinc matters — excess zinc competes with copper absorption and can be problematic in certain populations, particularly those already supplementing with copper or on medications that affect zinc metabolism.

For those curious about specific dosing windows for zinc supplementation, timing zinc picolinate with or without food affects both absorption and tolerability and is worth reviewing alongside any SIBO gut-repair protocol.

---

NAC and Biofilm Disruption

One underappreciated reason SIBO persists despite treatment is bacterial biofilm formation. Bacteria in the small intestine can form protective biofilm matrices — structured communities encased in exopolysaccharides — that shield them from both antibiotics and herbal antimicrobials, reducing antimicrobial penetration by up to 1,000-fold compared to planktonic (free-floating) bacteria. N-acetylcysteine (NAC) disrupts biofilms by cleaving the disulfide bonds within the extracellular matrix and reducing the viscosity of the biofilm scaffold. A 2020 in-vitro study demonstrated NAC's ability to reduce E. coli and Staphylococcus biofilm formation by over 60% at concentrations achievable with oral supplementation. In clinical practice, NAC is typically used at 600–1,800 mg/day in biofilm-disruption protocols, started 1–2 weeks before the antimicrobial phase to dismantle existing biofilms before the antimicrobial agents arrive — a sequencing detail that matters practically.

Interestingly, NAC's utility extends beyond the gut. For a deeper look at NAC's mechanisms across gut and brain tissue, the clinical evidence behind NAC is worth reviewing — the same antioxidant and anti-inflammatory pathways that benefit neurological function also appear relevant to intestinal epithelial protection, particularly via glutathione replenishment in mucosal cells under oxidative stress from LPS exposure.

Enzyme-based biofilm disruptors — including serrapeptase and nattokinase — are increasingly used alongside NAC in clinical protocols. These enzymes degrade fibrin and polysaccharide components of the biofilm matrix through different mechanisms than NAC's thiol chemistry, suggesting potential additive benefit, though human RCT data in SIBO-specific populations remains limited.

---

What This Means for Your Formula

One of the central challenges with SIBO is that the right supplement protocol depends heavily on which variant you have (hydrogen-dominant, methane-dominant, or hydrogen sulfide-dominant), your motility status, and concurrent conditions like hypochlorhydria or histamine intolerance. A generic multivitamin does nothing to address any of these levers.

Ones takes a different approach by analyzing blood work, wearable data, and health history to identify the downstream deficiencies and system imbalances that make SIBO more likely to recur. For instance:

  • Zinc (as zinc picolinate, 15–30 mg): Ones includes clinically dosed zinc for gut mucosal integrity and immune defense in relevant formulas — not as a token ingredient but at the dose shown to support tight-junction repair in the zinc-carnosine literature.
  • Vitamin D3 + K2 (MK-7): Low vitamin D is associated with increased intestinal permeability and reduced mucosal immunity. Ones calibrates D3 dose to your actual lab value rather than applying a flat 1,000 IU to everyone.
  • Histamine Support (proprietary System Blend): SIBO commonly elevates histamine because dysbiotic bacteria are prolific histamine producers. Ones' Histamine Support blend addresses the DAO enzyme pathway that clears dietary and bacterial histamine — a mechanistically appropriate pairing with antimicrobial therapy.
  • Liver Support (proprietary System Blend): Bile acid production is essential for small-intestinal antimicrobial defense. Impaired bile flow is a recognized SIBO risk factor, and Ones' Liver Support blend targets the hepato-biliary axis relevant to this mechanism.

Formulas are built as 6 or 9-capsule daily plans, calibrated to what your data shows — not a plan you pick off a shelf.

---

Key Takeaways

  • Herbal antimicrobials are clinically competitive with rifaximin for breath-test normalization in SIBO, based on a randomized trial of 104 patients; the herbal arm achieved 46% normalization versus 34% for rifaximin (Chedid et al., 2014; PMID: 24891990).
  • Berberine, oregano oil, and allicin are the best-studied botanicals; allicin has specific activity against methane-producing archaea in IMO, and berberine carries significant drug-interaction potential at therapeutic doses.
  • Probiotics work best post-treatment, not during — strain selection (soil-based organisms or large-intestinal Bifidobacterium species) and timing matter significantly; standard Lactobacillus products can worsen symptoms in active SIBO.
  • Low stomach acid is both a cause and consequence of SIBO; betaine HCl, zinc-carnosine, and DGL support gastric mucosal integrity without the SIBO-aggravating risk of long-term PPIs, which increase SIBO odds by roughly 2.3-fold.
  • NAC at 600–1,800 mg/day can disrupt bacterial biofilms that protect pathogens from antimicrobial treatment; starting NAC 1–2 weeks before the antimicrobial phase improves coverage.
  • Personalized formulas calibrated to your lab data — including zinc, vitamin D3, and system-specific blends for histamine and liver function — address SIBO's root causes more precisely than general gut health stacks.

Always consult a licensed healthcare provider before beginning any SIBO protocol, particularly if you are on prescription medications or have confirmed intestinal conditions.

Written by Jared Murray, Co-Founder & Head of Health Research, Ones.

Jared is the co-founder and head of health research at Ones, with 25 years applying nutrition science, biomarker interpretation, and clinical supplementation research to individual health programs. He leads the editorial process for the Ones Health Library, where lab data, wearable biometrics, and peer-reviewed clinical research are translated into evidence-based, personalized supplement guidance.

Disclosure: Ones formulates and sells personalized supplements that may include ingredients discussed in this article. We have a financial interest in the products mentioned. Recommendations are based on published research and our editorial standards, not sales targets.

This article is educational content, not medical advice. Consult a healthcare provider before changing your supplement regimen.

Further reading

Related reading